Contracting Human Immunodeficiency Virus (HI Virus) in western civilization no longer means living in fear. While taking the medication, Highly Active Anti-Retroviral Therapy (HAART), the virus cannot be spread. Therefore allowing the patient to remain sexually active and procreate without passing on HI Virus to others. This treatment causes the HI Virus enter into a of hibernation phase, allowing the infected person to live a more normal life. Even though it sounds like a miracle drug, the geographical areas that are most affected by this virus are not being treated. This essay will discuss why this medication is not the final answer. How HAART is not available to the countries that need it most, and even though a true cure has been found,
According to the authors of Chapter 5, the single factor that explains the sharp drop in mortality in the U.S. was the introduction of Highly Active Antiretroviral Therapy (HAART) in 1996. HAART, medications including at least two different classes/kinds of ARVs, was found to suppress the virus and restore patients’ immune systems for sustained periods.
Since the outbreak of HIV/AIDS, an estimated 78 million people have acquired HIV and has killed approximately 39 million people infected with the virus. The prognosis of the epidemic has continued to vary from different countries and according to global statistics; 35 million people in 2013 were living with HIV/AIDS. 2.5 million People per annum acquire the virus and 1.5 million die of AIDS. Inspite of the drastic transmission of the HIV/AIDS epidemic, the development and accessibility of anti-retroviral drugs has decreased mortality rates by 22% from a population of 2.0million in 2009 to 1.5million in 2013 (WHO, 2013),
Introduction: Human Immunodeficiency Virus (HIV) has become a global issue that has infected an estimated 35 million people living today1. The strain HIV-1 has been of experimental concern for years in hopes of a cure. This retrovirus directly infects the immune system by binding helper T-cells via the CD4 receptor. This allows for integration of the viral RNA into the T-cells, and causes the immune system to weaken by killing these immune cells. Advancements in research led to the use of highly active anti-retroviral therapy (HAART) for treatment, however this does not cure the patient of HIV but it suppresses the viral replication of HIV-1 to very low levels2.
Treatment for HIV has improved drastically over the last 20 years. Antiretroviral drugs are medication that attack and destroy the retrovirus. In 1995, the FDA approved antiretroviral therapy (ART). This is where the patient takes two to three types of medication, as single therapy is not advised, this improves treatment as the different drugs work together to combat the virus. Haart is an antitrtrovirus therapy, which was introduced in 1996. It has shown to reduce death rate and hospital admission; it has also shown to decrease transmission of the disease. The use of haart in developing countries has shown a huge reduction in mortality and morbidity, associated with HIV, also seen to slow progression of AIDS. This is due to is lowering viral load in the patients’ blood and sexual fluids. In Antiretroviral dug used in these therapies are very important, the combination of drugs work by stopping the virus from replicating. Also the anti-retroviral medicine used, in many cases can increase their CD4 and their T cell counts. This will leading to patients quality of life improving and allowing longevity of life. This has shown to be a huge advance help improve patients’ lives and the life expectancy of people who live with HIV/AIDS.
The data was nationally collected to determine Sweden’s progress in reaching the 90-90-90 goal. By the end of 2015, Sweden had reached and surpassed the UN’s goal. They had 90% of cases diagnosed, 99.8% of people were linked to antiretroviral therapy and 95% of people taking antiretroviral for 6 months or more had a viral load below 50 copies/ml (Carter). The use of antiretroviral therapy in many patients who have HIV has reduced
Human immunodeficiency virus (HIV)/AIDS is a pandemic problem affecting global health. At the end of 2015, 36.7 million people were living with HIV/AIDS globally. The rate of incidence is more prevalent in Sub-Saharan Africa with almost 1 in every 24 adults living with HIV/AIDS. In the united states, HIV/AIDS is a diversified health problem affecting all sexes, ages and races and involving the transmission of multiple risk behavior. However, with the introduction of various prevention programs and antiretroviral drugs, the incidence of HIV/AIDS has reduced.
Since its outbreak the Human immunodeficiency virus (HIV) which goes on to develop in to Acquired immune deficiency syndrome (AIDS) has been reported in over 119 countries with 78 million people being infected resulting in over 39 million deaths. As of 2013 an estimated 0.8% of the world’s population aged 15-49 are living with HIV, this varies dramatically for individual countries with it rising to 71% in sub-Saharan Africa [ ]. This has lead to a dramatic decrease in life expectancy as shown in figure 1[ ]; this intern reduces the working population causing economical impacts. Recent recovery in life expectancy is due as a result in our increased understanding of how HIV replicates, allowing for the development of drugs that interrupts its
The discovery and implementation of antiretroviral therapy (ART) changed the prognosis for many with HIV from a fatal death sentence to a manageable chronic disease which enables sufferers to lead full lives. 96% of people living with HIV in the UK accessed ART treatment (Figure 2) in 2016.
The scaling up of ART follows the public health approach of using the standardized and simplified treatment regimens that are consistent with international standards (Bennett et al., 2012). However the treatment with ARV drugs can be accompanied by emergence and transmission of HIV DR. The emergence of HIV DR can limit the treatment options that will need switching to the second-line regimens that is costly and can produce long term toxicities (Bennett et al., 2012). In order to counter the effects of HIV DR, WHO developed a global strategy for the prevention and minimizing the emergence of HIV DR (Bennett et al., 2008, 2012). The WHO strategy involves three elements:
33.3 million people are infected or living with HIV, of which 22.5 million are in sub-Saharan Africa. In addition, of the2.5 million children in the world estimated to be living with HIV, 2.3 million are in sub-Saharan Africa. Southern Africa, the most affected region, includes a number of middle- and lower-middle-income nations known as the hyperendemic countries. In South Africa alone, there are about 5.7 million people living with HIV/AIDS. In Swaziland, 42 per cent of women attending antenatal clinics are infected, with similar rates found elsewhere in the region. Many children are affected by the disease in a number of ways: they live with sick parents and relatives in households drained of resources due to the epidemic, and those who have lost parents are less likely to go to school or continue with their education.Studies in the regions of Southern Africa and South-East Asia have found HIV/AIDS to negatively impact both the demand for and supply of education.1,2 Orphaned children are either pulled out of school or not enrolled at all due to the financial constraints of their affected families, and have to assume responsibilities of heading or providing for households. In this respect, girls are more vulnerable. In Kenya, links were found between parental deaths and children 's progress through school. In Tanzania, households that have experienced an adult death have been found to delay the enrolment of younger children in school, but try to keep older children
Human Immunodeficiency Virus (HIV), is a viral infection that attacks the immune system, which then results in a slow progression of this illness. This viral infection can lead to further infections as well as possible cancer. Once the immune system can no longer continue its battle with HIV, this leads to what is commonly known as Acquired Immunodeficiency Syndrome. HIV/AIDS is a common and devastating concern in many households, and has been a longstanding health issue affecting sub Saharan Africa. However, it should also be noted that countries around the world are all at risk of HIV/AIDS infection through the migration of people to their region. HIV/AIDS is a much more prominent health concern characterizing sub Saharan Africa because of the treatment of women in society, extreme poverty resulting in the lack of education for people and access to basic needs, and government inaction to address the HIV/AIDS epidemic.
Almost 36.9 million people are currently living with HIV infection and almost 10 million people being died from the infection or as a result related causes or opportunistic infections. At present people acquired the infection reported from all regions in the world. The majority of old and new cases are reported from sub-Saharan Africa which accounts for almost 70%. Most of the HIV infection affects people at their predictive life, and around 40% of the infection occurs in young youth at age less than 25 ys. (Global Health policy, 2014).
The Human Immunodeficiency virus (HIV) is a virus that causes Acquired Immunodeficiency Syndrome (AIDS). HIV and AIDS gravely reduces a person’s immune system allowing them to be more susceptible to serve infections. At the end of 2009, the Center for Disease Control and Prevention (CDC) estimated 1,148,200 people over the age of 13 in the United States were infected with HIV. The CDC estimates that the incidence every year is 50,000 people. (2) The main treatment therapy is highly active antiretroviral therapy (HARRT). This therapy utilizes nucleoside/nucleotide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors to prevent replication of HIV. This extends the latency period of HIV,
Human Immunodeficiency Virus (HIV) is a virus that infects the cells of human immune system, causing destruction and impairing the cellular functions. Progressive deterioration of the immune system at cellular level causes associated infection to undermine the immune system putting the patient at risk of opportunistic infections. Acquired Immunodeficiency Syndrome (AIDS) is the most advanced stage of HIV. AIDS is caused when HIV related cancers hit the immune system by 20 or more opportunistic infections. According to the World Health Organization (WHO) by the end of 2016, 36.7 million people (30.8-42.9 million) were living with HIV globally. Approximately 0.8% (0.7%-0.9%) adults between the age group of 18-45 were living with HIV and 76%